Roussy, Gustave

(redirected from Gustave Roussy)
Also found in: Wikipedia.

Roussy,

Gustave, French pathologist, 1874-1948.
Dejerine-Roussy syndrome - see under Dejerine
Roussy-Cornil syndrome - occasional lancinating pains, with peripheral weakness, fasciculation, visual disturbance, and ataxia. Synonym(s): interstitial hypertrophic neuropathy
Roussy-Lévy disease - a type of cerebellar ataxia regularly associated with wasting of the calves and intrinsic muscles of the hands, with absent tendon reflexes. Synonym(s): Roussy-Lévy syndrome
Roussy-Lévy syndrome - Synonym(s): Roussy-Lévy disease
References in periodicals archive ?
He is the general director of cancer center Gustave Roussy in Paris and a highly respected expert physician in the melanoma space.
Professor Alexander Eggermont is the general director of cancer centre Gustave Roussy in Paris and a physician in the melanoma space.
Research collaboration with Institut Gustave Roussy continues to study regulation of intestinal permeability and the gut microbiota using larazotide in immuno-oncology checkpoint inhibitor failure preclinical models
His Highness the Prime Minister Sheikh Jaber Al-Mubarak Al-Hamad Al-Sabah received Chairman of Gustave Roussy Institute of Oncology Alexander Eggermont KUWAIT, April 3 (KUNA) -- His Highness the Prime Minister Sheikh Jaber Al-Mubarak Al-Hamad Al-Sabah received, in the presence of Health Minister Sheikh Dr.
Sergey Nikolaev, Researcher, Gustave Roussy Cancer Center; France; and Dr.
ISLAMABAD -- The Swiss Ambassador Mr Thomas Kolly visited Comsats University Islamabad (CUI) on Friday on invitation of the CUI Rector with a three-member Swiss delegation comprising of Prof Stylianos E Antonarakis, University of Geneva Medical School, Switzerland; Prof Sergey Nikolaev, Researcher, Gustave Roussy Cancer Center; France;and Dr Muhammad Ansar, University of Geneva Medical School, Switzerland.
Antonio Di Meglio, study author and Medical Oncologist, Institut Gustave Roussy, France.
Kuwait will build a branch of the France-based cancer research institute Gustave Roussy, as part of the government's vision to build more hospitals.
of Gustave Roussy Cancer Campus and Paris Saclay University who was a Merit Award recipient supported by the Kidney Cancer Association, will use the grant to study the gut microbiome composition to predict resistance in renal cell carcinoma (RCC) patients on nivolumab.
Eggermont of Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif, France.
The principal investigator initiating this trial is Aurelien Marabelle, MD, PhD, Clinical Director of the Cancer Immunotherapy Program at Institut Gustave Roussy, Villejuif, France.